Home/Filings/4/0001225208-26-000647
4//SEC Filing

BOURLA ALBERT 4

Accession 0001225208-26-000647

CIK 0000078003other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 2:32 PM ET

Size

5.5 KB

Accession

0001225208-26-000647

Insider Transaction Report

Form 4
Period: 2026-01-14
BOURLA ALBERT
DirectorChairman & CEO
Transactions
  • Award

    Phantom Stock Units SSP

    [F1][F2]
    2026-01-14$25.58/sh+79$2,021743,136 total
    Common Stock (79 underlying)
Footnotes (2)
  • [F1]Each unit represents one phantom share of common stock.
  • [F2]These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Signature
/s/ Shanice A. Reid, by power of atty., for Albert Bourla|2026-01-16

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001595703

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 2:32 PM ET
Size
5.5 KB